Cargando…
PROState Pathway Embedded Comparative Trial: The IP3-PROSPECT study
INTRODUCTION: The traditional double blind RCT is the ‘gold standard’ trial design. For a variety of reasons, these designs often fail to accrue enough participants to conclude. This is particularly challenging in localized prostate cancer. The cohort multiple randomised controlled trial (cmRCT) tri...
Autores principales: | Bass, E.J., Klimowska-Nassar, N., Sasikaran, T., Day, E., Fiorentino, F., Sydes, M.R., Winkler, M., Arumainayagam, N., Khoubehi, B., Pope, A., Sokhi, H., Dudderidge, T., Ahmed, H.U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451266/ https://www.ncbi.nlm.nih.gov/pubmed/34139356 http://dx.doi.org/10.1016/j.cct.2021.106485 |
Ejemplares similares
-
Feasibility of Comparative Health Research Outcome of Novel Surgery in prostate cancer (IP4-CHRONOS): statistical analysis plan for the randomised feasibility phase of the CHRONOS study
por: Day, Emily, et al.
Publicado: (2021) -
Perceived patient burden and acceptability of MRI in comparison to PSA and ultrasound: results from the IP1-PROSTAGRAM study
por: Eldred-Evans, David, et al.
Publicado: (2023) -
Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography: The IP1-PROSTAGRAM Study
por: Eldred-Evans, David, et al.
Publicado: (2021) -
Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trial
por: Connor, Martin John, et al.
Publicado: (2021) -
Metastatic prostate cancer men’s attitudes towards treatment of the local tumour and metastasis evaluative research (IP5-MATTER): protocol for a prospective, multicentre discrete choice experiment study
por: Connor, Martin John, et al.
Publicado: (2021)